Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The 5-milligram (mg) maintenance dose (MD) of prasugrel in very elderly patients with
coronary artery disease produces a pharmacodynamic response within the same therapeutic range
as 10-mg MD in non-elderly patients.